BioSyent, Inc. (RX.V)
15.70
+0.20
(+1.29%)
CAD |
TSXV |
Aug 25, 16:00
BioSyent Shareholders Equity (Quarterly) : 45.84M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 45.84M |
| March 31, 2026 | 44.99M |
| December 31, 2025 | 41.47M |
| September 30, 2025 | 39.90M |
| June 30, 2025 | 37.60M |
| March 31, 2025 | 36.01M |
| December 31, 2024 | 35.00M |
| September 30, 2024 | 37.35M |
| June 30, 2024 | 35.42M |
| March 31, 2024 | 34.55M |
| December 31, 2023 | 34.76M |
| September 30, 2023 | 34.55M |
| June 30, 2023 | 33.07M |
| March 31, 2023 | 33.42M |
| December 31, 2022 | 33.36M |
| September 30, 2022 | 33.00M |
| June 30, 2022 | 32.73M |
| March 31, 2022 | 32.03M |
| December 31, 2021 | 31.55M |
| September 30, 2021 | 30.33M |
| June 30, 2021 | 28.81M |
| March 31, 2021 | 27.75M |
| December 31, 2020 | 26.80M |
| September 30, 2020 | 26.12M |
| June 30, 2020 | 25.09M |
| Date | Value |
|---|---|
| March 31, 2020 | 25.65M |
| December 31, 2019 | 25.79M |
| September 30, 2019 | 25.38M |
| June 30, 2019 | 24.81M |
| March 31, 2019 | 26.96M |
| December 31, 2018 | 27.61M |
| September 30, 2018 | 26.55M |
| June 30, 2018 | 25.18M |
| March 31, 2018 | 23.44M |
| December 31, 2017 | 22.21M |
| September 30, 2017 | 20.74M |
| June 30, 2017 | 19.36M |
| March 31, 2017 | 17.72M |
| December 31, 2016 | 16.73M |
| September 30, 2016 | 15.57M |
| June 30, 2016 | 14.24M |
| March 31, 2016 | 13.15M |
| December 31, 2015 | 12.15M |
| September 30, 2015 | 11.33M |
| June 30, 2015 | 10.09M |
| March 31, 2015 | 9.190M |
| December 31, 2014 | 8.160M |
| September 30, 2014 | 7.374M |
| June 30, 2014 | 6.338M |
| March 31, 2014 | 5.445M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | 78.37M |
| Bausch Health Cos., Inc. | -2.513B |
| Cipher Pharmaceuticals, Inc. | 194.73M |
| Revive Therapeutics Ltd. | -4.025M |
| Knight Therapeutics, Inc. | 798.59M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 60.46M |
| Total Liabilities (Quarterly) | 14.62M |
| Debt to Equity Ratio | 0.0685 |
| Current Ratio | 2.068 |
| Net Debt Paydown Yield | -0.26% |